Details
Category: Volume 09 Issue 04 April 2021
Hits: 781

Title: Clinical Profile of Patients with Heart Failure and Type 2 Diabetes Mellitus Admitted In IGIMS

Authors: Dr Arshad Ahmad, Dr Ravi Vishnu, Dr Bhim Ram, Dr Ved Prakash, Dr Faiyaz Ahmad Ansari, Dr Chandrakishore

 DOI: https://dx.doi.org/10.18535/jmscr/v9i4.24

Abstract

HF with concomitant diabetes mellitus may have further increase risk through different pathophysiologic, hemodynamic and neurohormonal abnormalities

Aim: To evaluate the clinical presentation of patients with heart failure who were also diabetic.

Method: 100 patients coming with signs and symptoms of HF who were diabetic, between May 2018 to April 2019 were selected.

Results: Among them 64 were male and 36 were female. All patients had SOB, next common symptoms were swelling. Commonest sign found in our patients were edema, second most common finding were basal crepitations. In our study 39 patients with LVEF >50% had HbA1c between 6% -9%. However 46 patients with this level of HbA1c had LVEF <50%. P value was >0.5 which was not significant. In our study the association between HbA1c and NYHA class was not significant.  In our study we found that as HbA1c level goes up there were more chances of diastolic dysfunction. P value was < 0.5, which is statistically significant.

Conclusion: Although DM and HF are each individually associated with considerable morbidity and mortality, they often occur together, which further worsens adverse patient’s outcomes, quality of life, and cost of care.

Keywords: Heart failure, Diabetes mellitus, HaemoglobinA1C (HbA₁c), Diabetic Cardiomyopathy, diastolic dysfunction, left ventricular (LV) hypertrophy.

References

  1. Arati A. Inamdar, Ajinkya C. Inamdar. Heart failure: Diagnosis, Management and utilization. J Clin Med. 2016 Jul;5(7) :62. Doi:10.3390/jcm 5070062
  2. Kaveeshwar SA, Cornwall J. The current status of diabetes mellitus in india.AMJ2014,7;1:45-48.
  3. David M, Nathan. The Diabetes Control and Complication Trial/ Epidemiology of Diabetes Interventions and Complication Study at 30 Years: Overview. Diabetes Care 2014 Jan; 37(1):9-16.
  4. Worldwide toll of diabetes. International Diabetes Federation Diabetes Atlas: 9th edition 2019.
  5. Sarma S, mentz RJ et al. Association between diabetes mellitus and post-discharge outcomes in patients hospitalised with heart failure: finding from the EVEREST trial. Eur J Heart Fail 2013;15: 194-202.
  6. Giuseppe M C Rosano, Cristiana Vitale, Peter Seferovic. Heart Failure in Patients with Diabetes mellitus. Cardiac Failure Review.2017 Apr;3(1):52-55.
  7. Nicholas GA, Gullion Cm, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care.2004;27:1879-1884.
  8. Bertoni AG, Hundley WG et al. Heart failure prevalence, incidence and mortality in the elderly with diabetes. Diabetes Care.2004; 27:699-703.
  9. Shannon M. Dunlay, Michael M et al. Type2 diabetes mellitus and heart failure: A scientific statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation. 2019;140(7):e294-e324.
  10. Dei Cas A, Khan SS et al.Impact of diabetes on epidemiology, treatment and outcomes of patients with heart failure. JACC Heart Fail.2015; 3:136-145.
  11. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiology.1972;30: 595-602.
  12. Gheorghiade M, Bӧhm M, Greene SJ et al, Effect of aliskiren on post discharge mortality and heart failure readmissions among patients hospitalised for heart failure: the ASTRONAUT randomised trial. JAMA 2013;309:1125-35.
  13. Scirica BM, BhattDL, Braunwald E, wt al, SAVOR_TIMI 53 Streering Committee and Investigators. Saxagliptins and cardiovascular outcomes in patients with type 2 diabetes mellitus. N England J Med 2013; 369:1317-26.
  14. John J. V. McMurray, Scott D Solomon et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019; 381:1995-2008.
  15. Levelt E, Mahmood M et al. Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes. Diabetes.2016; 65:44-52.
  16. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol.2003; 41:611-617.

Corresponding Author

Dr Bhim Ram

Assistant Professor, Deptt of General Medicine, IGIMS, Sheikhpura, Patna, Bihar, India